This is a UK news story, published by Wired, that relates primarily to GLP-1 news.
For more UK news, you can click here:
more UK newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Wired, you can click here:
more news from WiredOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest health promotion drugs news, older diabetes drug news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
first weight loss medicationWired
•
75% Informative
Two GLP-1 agonists, known as Ozempic and Wegovy , may be even more effective at shedding pounds.
The drugs were originally developed to help control diabetes.
They seem to boost heart health, protect the kidneys, improve sleep apnea, and lower the risk of certain obesity-related cancers.
GLP-1 drugs may calm inflammation in the brain, raising hope that they could be used to treat conditions like dementia and Parkinson’s disease.
In a UK trial of 200 people with mild Alzheimer's disease, an older drug called liraglutide appeared to slow shrinking of the parts of the brain that control memory, learning, language, and decisionmaking by as much as 50 percent .
VR Score
63
Informative language
55
Neutral language
59
Article tone
informal
Language
English
Language complexity
50
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
10
Source diversity
8
Affiliate links
no affiliate links